Abbott Launching ID NOW COVID-19 Tests, Offering Positive Results in Five Minutes
Company expects to deliver 50,000 tests per day of the rapid, instrument-based, isothermal system designed for qualitative detection of infectious diseases.
New Study Suggests COVID-19 Reinfection Unlikely
The study used four adult Chinese rhesus macaques and found that those monkeys that had been re-exposed to SARS-CoV-2, like the unexposed control monkey, showed no recurrence of COVID-19.
Biomarker of Female Precancer Risk from HPV Found in Microbiome
Gardnerella bacteria were the dominant biomarker for the progression of HR-HPV and its effect is mediated by increased cervicovaginal bacterial diversity directly preceding the progression of a persistent infection to precancer.
U.K. to Use Nanopore Sequencing to Map COVID-19 Spread
A notable addition to the effort is a team from the University of Birmingham, led by Nick Loman, Ph.D., professor of Microbial Genomics and Bioinformatics in the Institute of Microbiology and Infection, whose lab is known for fusing cutting-edge sequencing with microbial genomics.
Triple negative breast cancer might not actually be ‘breast cancer’
The study could signal a potential treatment breakthrough for patients with this form of breast cancer, which disproportionately affects and tends to develop more aggressively in black women.
Genetic Study Shows Coronavirus Evolved Naturally, Is not Lab-Constructed
Scripps researchers compare available genome sequence data for known coronavirus strains to determine that that SARS-CoV-2 originated through natural processes and note that their results “clearly show that SARS-CoV-2 is not a laboratory construct or a purposefully manipulated virus.”
Small Sequencer Developer GenapSys Completes $90M Series C Financing
GenapSys’ sequencing system is about the size of an iPad, costs under $10,000, and is based on a proprietary direct electronic sequencing chip, which is intended to eliminate the need for cumbersome equipment.
Biodesix, Bio-Rad Pursue FDA EUA Approval for ddPCR-Based COVID-19 Test
Emergency Use Authorization (EUA) would enable Biodesix and Bio-Rad to begin testing in the U.S. using the Droplet Digital PCR system.
Cepheid, Sherlock to Develop Coronavirus Test, Part of Broader MDx Collaboration
The companies will partner on a proof-of-concept project focused on detection of SARS-CoV-2 coronavirus as the first initiative of a broader collaboration focused on developing molecular diagnostic tests for infectious diseases and oncology.
20 Molecular Diagnostics Companies to Watch
Up-and-Coming Diagnostic Test Developers Emerge as Consolidation Thins the Field.
